BioSpace News Archive

Business

Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson

Johnson & Johnson announced that Dominic J. Caruso, Executive Vice President, Chief Financial Officer, has elected to retire in September 2018 after a distinguished 19-year career with the Company.

March 20, 2018
·
2 min read
Business

Merck Announces Appointment of Jennifer Zachary as General Counsel

Merck announced the appointment of Jennifer Zachary as general counsel, effective April 16, 2018.

March 20, 2018
·
2 min read
Business

Synlogic Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

Synlogic Inc. reported its financial results for the fourth quarter and full year ended December 31, 2017.

March 20, 2018
·
6 min read
Business

Arrowhead Pharmaceuticals Reports Inducement Grants To Six New Employees under NASDAQ Marketplace Rule 5635(c)(4)

Arrowhead Pharmaceuticals, Inc. announced that as an inducement to entering into employment with the Company, on March 16, 2018, the Board of Directors approved “inducement” grants to six new employees.

March 20, 2018
·
1 min read
Business

NovaBay Pharmaceuticals Reports 2017 Fourth Quarter and Full Year Financial Results

NovaBay Pharmaceuticals Inc reports financial results for the three and 12 months ended December 31, 2017 and provides a business update.

March 20, 2018
·
5 min read
Business

Biotech Big Bangs Its Way Into New York City Via Beacon Capital’s Incubator

Beacon Capital released the introduction of a unique NYC incubator initiative “Beacon Pharma.

March 20, 2018
·
1 min read
Business

TSO3 Reports Fourth Quarter and Full Year 2017 Results

TSO3 Inc. reported financial results for the fourth quarter and year ended December 31, 2017.

March 20, 2018
·
9 min read
Job Trends

AMPLEXOR’s March Webinar Program Addresses Major Life Sciences Challenges - Ensuring Patient Safety in Localization and Achieving Best Practice in Regulatory Master Data Management

The Life Sciences division of AMPLEXOR has announced its March 2018 webinar program, with two webinars that aim to address challenges facing those in the life sciences industry.

March 20, 2018
·
2 min read
Biotech Beach

Xencor Announces Pricing of Public Offering of Common Stock

Xencor announced the pricing of an underwritten public offering of 7,300,000 shares of its common stock at a price to the public of $31.00 per share.

March 20, 2018
·
2 min read
Genetown

Proteostasis Therapeutics Announces Withdrawal of Equity Offering Due to Market Conditions

Proteostasis Therapeutics, Inc. announced that it is not proceeding with its proposed public offering of 9,000,000 shares of its common stock in an underwritten public offering previously announced on March 19, 2018.

March 20, 2018
·
1 min read